Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
162401-32-3
|
| gptkbp:developedBy |
HIV/AIDS treatment
|
| gptkbp:hasMolecularFormula |
C17H19N5O2
|
| gptkbp:hasSMILES |
CC1=C(C(=CC=C1)NC2=NC(=NC=C2C3=CC=CC=N3)C(=O)N)C
|
| https://www.w3.org/2000/01/rdf-schema#label |
VRC-353
|
| gptkbp:isAntiviralAgent |
true
|
| gptkbp:isNonNucleosideReverseTranscriptaseInhibitor |
true
|
| gptkbp:isNucleosideAnalogue |
false
|
| gptkbp:IUPACName |
2-(2,6-dimethylanilino)-4-(2-pyridinyl)pyrimidine-5-carboxamide
|
| gptkbp:PubChem_CID |
CHEMBL2103862
9843482 |
| gptkbp:synonym |
2-(2,6-dimethylanilino)-4-(2-pyridinyl)pyrimidine-5-carboxamide
VRC353 |
| gptkbp:target |
HIV-1 reverse transcriptase
|
| gptkbp:bfsParent |
gptkb:Clansman_radio_system
|
| gptkbp:bfsLayer |
6
|